肿瘤系列二多发性骨髓瘤BCMA靶向疗法推向前线724

Summary of Conference Call Company or Industry Involved - The conference call pertains to New South Research Institute and its services to whitelist clients Core Points and Arguments - The call serves as a principle statement regarding changes in service for clients of New South Research Institute [1] - It is emphasized that the content of the call does not constitute investment advice [1] - The company disclaims any responsibility for investment losses incurred by investors using the content of the call [1] - Expert opinions shared during the call represent personal views and do not reflect the company's stance [1] Other Important but Possibly Overlooked Content - The call is primarily focused on compliance and legal disclaimers rather than specific financial or operational insights [1]